Jochen Salfeld talks about HUMIRA® and the development of biological therapies at Abbott
Raju Kucherlapati talks about personalised medicine: breathing new life into old drugs
Graham Dixon talks about his career, his involvement with the Society for Chemical Industries and the development of SCIpharm2006
Steve Carney talks to Mark Ashton and Mark Whittaker about Evotec and their approach to fragment-based drug discovery
Question: what do you call 500 scientists coming together to address the productivity gap? Answer: a start
Rob Ashley of AmpliMed discusses the discovery and development of Imexon
KDI tripeptide from laminin: a novel approach to treat neurodegenerative disorders
Axel Unterbeck on memory, cognition and the development of CNS drugs
John Anson of GE Healthcare
Steve Carney talks to Vincent Lee on the pharma industry, the FDA and public education with respect to drugs and their development
Andy Southan talks about ion channel research services at BioFocus
Joseph Miletich talks about big Pharma, biotech and the future of Amgen
Chris Ashton talks about his career and the recent merger of Argenta Discovery and Etiologics
Eric Kandel: A life in learning and memory
How can we avoid the productivity gap?
Clear Vision Strategies Sourcing Maturity Model